IgG-mediated modulation of antibody production and B cell memory to malaria: Rol
IgG 介导的抗体产生和 B 细胞对疟疾记忆的调节:Rol
基本信息
- 批准号:8477355
- 负责人:
- 金额:$ 23.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:12 year oldAcuteAdultAfricaAgeAllelesAmino AcidsAntibodiesAntibody FormationAntigen PresentationAntigen-Antibody ComplexAntigensAntimalarialsAreaAsiaB-Cell DevelopmentB-LymphocytesBindingBiologicalBiological AssayBloodCellsCerebral MalariaChemoprophylaxisChildChildhoodClinicalDataDevelopmentErythrocytesFCGR2B geneFeedbackFlow CytometryFrequenciesGenerationsGenesGenetic PolymorphismGoalsHomologous GeneImmuneImmunityImmunoglobulin GIndividualInfectionInflammatoryInflammatory ResponseInstitutional Review BoardsInterferonsInterleukin-10KnowledgeLifeLinkMaintenanceMalariaMalaria VaccinesMeasuresMediatingMemoryMemory B-LymphocyteMicroarray AnalysisMolecularMononuclearMorbidity - disease rateMusMutationPapua New GuineaParasitemiaParasitesPeripheral Blood Mononuclear CellPhagocytesPhenotypePlasma CellsPlasmodium falciparumPopulationPredispositionPreschool ChildProtocols documentationPublic HealthReceptor ActivationReceptors, Antigen, B-CellResearchSNP genotypingSamplingSerumSignal TransductionStagingSymptomsT-LymphocyteTNF geneTestingTetanus ToxoidUnited States National Institutes of HealthVaccinesacquired immunitybasecytokinedensitydesignexperiencemutantnovelresponsetransmission processvector control
项目摘要
Naturally acquired immunity (NAI) to high-density parasitemia and clinical illness from P. falciparum (Pf) and
P. vivax (Pv) infection develops slowly during childhood and wanes in the absence of periodic boosting from
blood stage infection. Serum IgG antibodies are critical for development of this acquired immunity. The slow
acquisition of NAI arises, in part, from an impaired ability to generate persisting malaria-specific memory 8
cells (MBC) and resulting long-lived Ab secreting plasma cells (LLPC) to a broad repertoire malaria Ags.
Blood stage Pf and Pv may suppress generation and maintenance of malaria MBC and LLPC by virtue of
their high Ag loads that elicit systemic pro-inflammatory responses, e.g. increased TNF-a, IFN-y which are
eventually down-regulated (possibly explaining, in part, why many malaria infected children in endemic areas
are asymptomatic). In the current proposal we examine the hypothesis that the inflammatory milieu elicited
by repeated malaria infections among individuals with little or no NAI, e.g. young children and malaria naive
adults, upregulates potent inhibitory feedback loops that impair generation and maintenance of MBC and
LLPC. A central goal of research here is to establish a link between susceptibility to malaria infection and
uncomplicated morbidity and the ability to generate and sustain malaria Ag-specific MBC. We will evaluate
and compare these relationships with respect Pf and Pv since NAI to Pv develops more rapidly than to Pf
under conditions of similar transmission in Papua New Guinea (PNG). The studies will be performed with
collaborators from West Africa and NIH in order to determine whether these features of NAI are generalized
across populations that diverge genetically and epidemiologically. While immune regulatory mechanisms will
be considered broadly using gene microarray analysis of known or suspected feedback loops, inhibitory
FcyRIIB that regulates the B cell receptor (BCR) activation threshold by binding malaria Ag immune
complexes (IC) will be evaluated specifically. We will use biological samples and clinical/parasite data from
children and adults exposed to Pv and Pf in PNG under the auspices of approved IRB protocols of the SW
Pacific ICEMR. The specific objective of the project are: i) Correlate the degree of NAI with malaria Agspecific
MBC frequency, breadth and durability; ii) Determine the immunoregulatory networks elicited by
acute malaria and their relation to generation Pf MBC; (iii) Assess whether FCGR2B functional
polymorphisms impact NAI and malaria Ag-specific MBC development.
自然获得性免疫(NAI)对高密度寄生虫病和恶性疟原虫(Pf)的临床疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher L King其他文献
Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents
在疗养院居民中接种 XBB.1.5 疫苗对先前的 SARS-CoV-2 毒株和 JN.1 变异体具有广泛的免疫原性
- DOI:
10.1101/2024.03.21.24303684 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Yasin Abul;Clare Nugent;Igor Vishnepolskiy;Tiffany Wallace;Evan Dickerson;Laurel Holland;Iva Esparza;Mandi Winkis;Kazi Tanvee Wali;Philip A Chan;Rosa R. Baier;Amy Recker;Matthew Kaczynski;Shreya Kamojjala;Alexander Pralea;Hailee Rice;Olubunmi Osias;Oladayo A. Oyebanji;Olajide J. Olagunju;Yi Cao;Chia Jung Li;Alex Roederer;Walther M. Pfeifer;Christopher L King;J. Bosch;Aman Nanda;Lynn McNicoll;Nadia Mujahid;S. Raza;Rohit Tyagi;Brigid M Wilson;Elizabeth M. White;David H Canaday;Stefan Gravenstein;A. Balazs - 通讯作者:
A. Balazs
Evaluating PK/PD Relationship of CNS Drug by Using Liquid Chromtography/ Tandem Mass Spectrometry Coupled to In Vivo Microdialysis
使用液相色谱/串联质谱联用体内微透析评估中枢神经系统药物的 PK/PD 关系
- DOI:
10.5772/33100 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Y. Qu;L. Olson;X. Jiang;L. Aluisio;Christopher L King;E. Jones;T. Lovenberg - 通讯作者:
T. Lovenberg
Christopher L King的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher L King', 18)}}的其他基金
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
使用人单克隆抗体确定间日疟疾的保护性免疫目标
- 批准号:
10353401 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
使用人单克隆抗体确定间日疟疾的保护性免疫目标
- 批准号:
10132239 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
使用人单克隆抗体确定间日疟疾的保护性免疫目标
- 批准号:
10599119 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
SARS-CoV-2 感染体液免疫的早期驱动因素
- 批准号:
10222232 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
SARS-CoV-2 感染体液免疫的早期驱动因素
- 批准号:
10680626 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Defining targets of protective immunity to vivax malaria using human monoclonal antibodies
使用人单克隆抗体确定间日疟疾的保护性免疫目标
- 批准号:
9973847 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
SARS-CoV-2 感染体液免疫的早期驱动因素
- 批准号:
10855050 - 财政年份:2020
- 资助金额:
$ 23.58万 - 项目类别:
Defining targets of protective immunity in Plasmodium vivax using human monoclonal antibodies
使用人单克隆抗体确定间日疟原虫保护性免疫的目标
- 批准号:
10651591 - 财政年份:2014
- 资助金额:
$ 23.58万 - 项目类别:
Strain-specific Immunity to Plasmodium vivax malaria
对间日疟原虫疟疾的菌株特异性免疫
- 批准号:
8542980 - 财政年份:2014
- 资助金额:
$ 23.58万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 23.58万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 23.58万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 23.58万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 23.58万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 23.58万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 23.58万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 23.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 23.58万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 23.58万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 23.58万 - 项目类别:














{{item.name}}会员




